Viewing Study NCT02814461


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-05-25 @ 9:11 AM
Study NCT ID: NCT02814461
Status: COMPLETED
Last Update Posted: 2019-09-23
First Post: 2016-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC
Sponsor: Shin Kong Wu Ho-Su Memorial Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Hepatocellular Carcinoma (HCC) View
Keywords: